iQure Pharma: Funding, Investors & Team (Sep 2026)
iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that specializes in creating innovative treatments on a global scale.
iQure Pharma has raised $1.7M across 3 funding rounds on record, the most recent an undisclosed round announced in Jun 2026.
iQure Pharma Company Profile and Key Stats
Latest funding round on record: Jun 2026.
iQure Pharma Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
iQure Pharma raised $220k in an undisclosed round announced in Apr 2024.
1.6 years later, an undisclosed round of $1.5M was announced in Nov 2025.
7 months later, an undisclosed round was announced in Jun 2026 with no disclosed amount.
iQure Pharma Founders and Leadership Team
Contact details for the iQure Pharma team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →iQure Pharma Funding Compared to Other Biotechnology Startups
Funded Startups Like iQure Pharma in Biotechnology and Wilmington
Companies Similar to iQure Pharma
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
iQure Pharma Funding FAQs
What does iQure Pharma do?
iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that specializes in creating innovative treatments on a global scale.
How much funding has iQure Pharma raised?
iQure Pharma has raised $1.7M across 3 rounds on record.
When did iQure Pharma last raise funding?
iQure Pharma's most recent funding round on record was announced in Jun 2026. The amount was not disclosed.
Who founded iQure Pharma?
FundedIQ lists Henk De Wilde (Founder), Peter Schiemann (Founder) at iQure Pharma.
Where is iQure Pharma headquartered?
iQure Pharma is based in Wilmington, Delaware, United States.
How many employees does iQure Pharma have?
iQure Pharma is in the 1-10 employee band.
About FundedIQ's iQure Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iQure Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.